EQS-Adhoc
LifeWatch AG announces ending of Pharma Life litigation
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Legal Matter
LifeWatch AG announces ending of Pharma Life litigation
24.06.2015 / 07:00
Release of an ad hoc announcement pursuant to Art. 53 KR.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------
LifeWatch AG announces ending of Pharma Life litigation
Zug/Switzerland, June 24, 2015 - LifeWatch AG (SIX Swiss Exchange: LIFE), a
leading developer and provider of medical solutions and remote diagnostic
monitoring services in the digital health market, is pleased to announce
that on June 22, 2015, the Israeli Supreme Court issued judgment in the
parties appeals in the case of Pharma Life Ltd vs. Cardguard Survival Ltd
(now LifeWatch Technologies Ltd), thus ending nearly 15 years of
litigation.
The decision reversed a large portion of the judgment against LifeWatch
Technologies, a wholly owned subsidiary of LifeWatch AG, and will result in
release/return of funds back to the company in the range of seven digit
figures in Swiss Francs. Additional details of the Supreme Court's decision
will be released in the near future.
For further questions:
LifeWatch AG
c/o Dynamics Group, Philippe Blangey / Doris Rudischhauser
Phone: +41 43 268 32 35 / +41 79 410 81 88
E-mail: investor-relations@lifewatch.com
About LifeWatch AG:
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solution company,
specializing in advanced digital health systems and wireless remote
diagnostic patient monitoring services. LifeWatch's services provide
physicians with critical information to determine appropriate treatment and
thereby improve patient outcomes. LifeWatch AG has operative subsidiaries
in the United States, in Switzerland and in Israel, and is the parent
company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd.
LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac
monitoring services and home sleep testing of Obstructive Sleep Apnea
(OSA). LifeWatch Technologies Ltd., based in Israel, is a leading developer
and manufacturer of telemedicine products. For additional information,
please visit www.lifewatch.com.
Sign up for customized e-mail alerts and documentation requests at
LifeWatch AG announces ending of Pharma Life litigation
Zug/Switzerland, June 24, 2015 - LifeWatch AG (SIX Swiss Exchange: LIFE), a
leading developer and provider of medical solutions and remote diagnostic
monitoring services in the digital health market, is pleased to announce
that on June 22, 2015, the Israeli Supreme Court issued judgment in the
parties appeals in the case of Pharma Life Ltd vs. Cardguard Survival Ltd
(now LifeWatch Technologies Ltd), thus ending nearly 15 years of
litigation.
The decision reversed a large portion of the judgment against LifeWatch
Technologies, a wholly owned subsidiary of LifeWatch AG, and will result in
release/return of funds back to the company in the range of seven digit
figures in Swiss Francs. Additional details of the Supreme Court's decision
will be released in the near future.
For further questions:
LifeWatch AG
c/o Dynamics Group, Philippe Blangey / Doris Rudischhauser
Phone: +41 43 268 32 35 / +41 79 410 81 88
E-mail: investor-relations@lifewatch.com
About LifeWatch AG:
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solution company,
specializing in advanced digital health systems and wireless remote
diagnostic patient monitoring services. LifeWatch's services provide
physicians with critical information to determine appropriate treatment and
thereby improve patient outcomes. LifeWatch AG has operative subsidiaries
in the United States, in Switzerland and in Israel, and is the parent
company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd.
LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac
monitoring services and home sleep testing of Obstructive Sleep Apnea
(OSA). LifeWatch Technologies Ltd., based in Israel, is a leading developer
and manufacturer of telemedicine products. For additional information,
please visit www.lifewatch.com.
Sign up for customized e-mail alerts and documentation requests at
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte